

Learn about common and serious Nisoldipine XR side effects, who's most at risk, how to manage them, and when to call your doctor or seek emergency care.
Every medication comes with potential side effects, and Nisoldipine XR is no exception. But here's the good news: most people tolerate it well, and the most common side effects are manageable. Knowing what to expect — and when something needs medical attention — helps you stay in control of your treatment.
This guide covers the common and serious side effects of Nisoldipine XR based on FDA labeling and clinical data, so you can have an informed conversation with your doctor.
Nisoldipine XR (brand name Sular, now available only as a generic) is a dihydropyridine calcium channel blocker prescribed to treat high blood pressure (hypertension) in adults. It works by relaxing blood vessels, which lowers blood pressure and reduces the workload on your heart. It's taken once daily as an extended-release tablet.
For a deeper look at what Nisoldipine XR is and how it's used, check out our complete overview.
These side effects are reported most frequently in clinical trials. Most are mild to moderate and tend to improve as your body adjusts to the medication:
Many of these side effects are related to the way Nisoldipine XR works — by relaxing blood vessels. As your blood vessels dilate, you may experience flushing, headache, dizziness, and swelling. These effects are often most noticeable in the first week or two of treatment.
Serious side effects are less common but require prompt medical attention. Call your doctor right away or seek emergency care if you experience any of the following:
Certain groups may need extra monitoring or dose adjustments:
People over 65 tend to have higher blood levels of Nisoldipine XR, which increases the risk of side effects like low blood pressure, dizziness, and edema. Doctors typically start elderly patients at the lowest dose (8.5 mg) and increase gradually.
If you have liver disease, Nisoldipine XR concentrations in your blood can be 4-5 times higher than in people with normal liver function. This dramatically increases the risk of side effects. Your doctor should start you at 8.5-10 mg and cap the dose at 30 mg/day.
There are no adequate studies of Nisoldipine XR in pregnancy. The American College of Obstetricians and Gynecologists (ACOG) generally prefers Nifedipine for pregnant women who need a calcium channel blocker. Nisoldipine may be excreted in breast milk, so breastfeeding is generally not recommended while taking it.
If you take CYP3A4 inhibitors like Itraconazole, Ketoconazole, or Clarithromycin, your Nisoldipine XR levels may rise significantly, increasing side effect risk. Check out our guide on Nisoldipine XR drug interactions for the full list.
If you're experiencing side effects, here are some practical tips:
If side effects persist beyond 2-3 weeks or significantly affect your quality of life, talk to your doctor. Options include adjusting your dose or switching to a different calcium channel blocker like Amlodipine or Nifedipine ER, which may be better tolerated.
Most people taking Nisoldipine XR experience mild side effects that improve over time. Swelling, headache, and dizziness are the most common and are usually manageable. Serious side effects are rare but important to recognize.
The key is staying in communication with your doctor. If you're experiencing side effects that concern you, don't suffer in silence — and definitely don't stop your medication without medical guidance. Your doctor can adjust your dose, manage symptoms, or find an alternative that works better for you.
If you need help finding Nisoldipine XR at a pharmacy near you, Medfinder can help you locate it in stock.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.